Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RN624 in osteoarthritis of the knee
NCT00394563Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in osteoarthritis (OA), sponsored by Pfizer. Started Mar 2006; status: completed.
02
Drugs
tanezumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00394563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394563.